Eva Sum
Impact in
-
- Gastrointestinal motility and disorders
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
Papers in ⓘ
- Oncology 4
- Cancer Treatment and Pharmacology 3
- HER2/EGFR in Cancer Research 2
- Cancer Immunotherapy and Biomarkers 1
- Peptidase Inhibition and Analysis 1
-
- Advanced Breast Cancer Therapies 3
- Co-authors
- Pablo Umaña (2 shared papers)Christine Trumpfheller (2 shared papers)Moritz Rapp (2 shared papers)Pedro Romero (2 shared papers)Jean Bourhis (1 shared paper)Christian Simon (1 shared paper)Vincent Roh (1 shared paper)Genrich V. Tolstonog (1 shared paper)
- Journals
- ESMO Open (3 papers)Clinical Cancer Research (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Digestive Diseases and Sciences (1 paper)Annals of Oncology (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Eva Sum
7 papers receiving 59 citations
Peers
Comparison fields: 5 of 30
- Gastroenterology 7
- Oncology 34
- Immunology 24
- Endocrine and Autonomic Systems 3
- Cancer Research 6
Countries citing papers authored by Eva Sum
This map shows the geographic impact of Eva Sum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Sum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Sum more than expected).
Fields of papers citing papers by Eva Sum
This network shows the impact of papers produced by Eva Sum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Sum. The network helps show where Eva Sum may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Sum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 27 | |
| 2 | 2022 | 17 | |
| 3 | 2008 | 10 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2025 | 1 |
About Eva Sum
Eva Sum is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Gastroenterology and Immunology, having authored 7 papers that have together received 59 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (3 papers), Cancer Treatment and Pharmacology (3 papers), HER2/EGFR in Cancer Research (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Peptidase Inhibition and Analysis (1 paper), Breast Cancer Treatment Studies (1 paper), Immune Cell Function and Interaction (1 paper) and Gastrointestinal motility and disorders (1 paper). The work is most often cited by research in Gastroenterology (7 citations), Oncology (34 citations), Immunology (24 citations), Endocrine and Autonomic Systems (3 citations) and Cancer Research (6 citations). Eva Sum has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Pablo Umaña, Christine Trumpfheller, Moritz Rapp, Pedro Romero, Jean Bourhis, Christian Simon, Vincent Roh, Genrich V. Tolstonog, Harald Dürr and Sara Labiano. Their work appears in journals such as ESMO Open, Clinical Cancer Research, Journal for ImmunoTherapy of Cancer, Digestive Diseases and Sciences and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.